TRIPS Waivers Act
Latest Action
Referred to the Committee on the Judiciary, and in addition to the Committee on Agriculture, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The TRIPS Waivers Act (H.R. 10103) was a bill introduced in the 118th Congress aimed at modifying or waiving certain provisions of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). The bill was referred to the House Committees on the Judiciary and Agriculture for consideration. However, no official summary or full text is available, and the bill ultimately failed or expired without further legislative action.
H.R. 10103 sought to address issues related to TRIPS waivers but did not advance beyond committee referral and expired without passage.
- The bill was introduced in the House during the 118th Congress and referred to relevant committees for review.
- No official summary or full text is publicly available, limiting detailed analysis of its provisions.
- The bill's status is recorded as failed or expired, indicating it did not progress to a vote or enactment.
["Potential beneficiaries could include sectors involved in international trade and intellectual property, such as pharmaceutical companies, agricultural businesses, and trade organizations, depending on the bill's specific provisions (which are not available).", 'Government agencies overseeing trade and intellectual property enforcement might also be affected.']
['Lack of available text and summary prevents assessment of implementation challenges or costs.', 'Unclear authority or oversight mechanisms due to missing bill details.', 'Potential trade-offs related to intellectual property rights and international trade obligations cannot be evaluated.']
The bill was introduced in the House and referred to the Judiciary and Agriculture Committees, reflecting jurisdictional interests in trade and intellectual property matters. The absence of further action and its failed/expired status suggest it did not gain sufficient legislative support or priority during the 118th Congress.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Potential impacts on international trade relations and intellectual property enforcement frameworks could have occurred if the bill had passed, but specifics are unavailable.', 'Changes to TRIPS waivers might influence pharmaceutical access, agricultural trade, or innovation incentives globally.']
The absence of an official summary and full text limits transparency and public oversight. The bill's referral to multiple committees indicates jurisdictional complexity, but the lack of further action and available documentation restricts comprehensive analysis. Monitoring similar future legislation with complete documentation is recommended for thorough evaluation.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.